Discovery of a potential new alternative to ReoPro, aspirin, and other anti-platelet agents used widely to prevent blood clots in coronary artery disease, stroke and heart attack is now being reported by scientists. Their study describes tiny peices of silver  (about 1/50,000th the diameter of a human hair) that are injected into the bloodstream.

Due to long standing issue of excessive bleeding that occurs as a bi-product of anti-blood clot drugs, the medical community is thrilled and optimistic about the possibilities of this new technology. By using silver particles, researchers are able to more gently orchestrate the activity of the platelets that cause clotting.

The silver particles “hold immense potential to be promoted as an antiplatelet agent,” explained the researchers. “Nanosilver appears to possess dual significant properties critically helpful to the health of mankind — antibacterial and antiplatelet — which together can have unique utilities, for example in coronary stents.”